Literature DB >> 9709753

The efficacy of focal laser therapy in radiation-induced macular edema.

P G Hykin1, C L Shields, J A Shields, J F Arevalo.   

Abstract

OBJECTIVE: The purpose of the study was to determine whether focal laser therapy improves or prevents deterioration of visual acuity in radiation-induced macular edema.
DESIGN: Retrospective review. PARTICIPANTS: The chart review of 19 patients. INTERVENTION: Comparison of 19 patients with radiation-induced macular edema secondary to radioactive scleral plaque application for choroidal melanoma managed by focal laser therapy with a matched group of 23 similar patients followed by observation.
RESULTS: Doubling of the visual angle occurred in 68% of all cases with 2 years of follow-up. At 6 months, 8 of 19 (42%) treated but no observed cases experienced > or = 1 Snellen line improvement in visual acuity (P = 0.005, Fischer's exact test), and the visual angle was halved in 3 of 19 (16%) treated but no observed cases at 6 months (P = 0.069). Resolution of macular edema occurred at 6 months in 5 of 19 (26%) treated and 1 of 23 (4%) observed cases (P = 0.21). No significant difference in visual acuity between the two groups was present after 2 years.
CONCLUSIONS: Progressive visual loss secondary to radiation-induced macular edema is rapid and severe. Focal laser therapy may modestly improve visual acuity and promote resolution of macular edema at 6 months, but benefit from single treatment is not sustained at 2 years.

Entities:  

Mesh:

Year:  1998        PMID: 9709753     DOI: 10.1016/S0161-6420(98)98023-X

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Long-term visual acuity results of treated and untreated radiation retinopathy (an AOS thesis).

Authors:  James L Kinyoun
Journal:  Trans Am Ophthalmol Soc       Date:  2008

2.  Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.

Authors:  Ivana K Kim; Anne Marie Lane; Purva Jain; Caroline Awh; Evangelos S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

3.  Post-brachytherapy tumor endoresection for treatment of toxic maculopathy in choroidal melanoma.

Authors:  T A McCannel
Journal:  Eye (Lond)       Date:  2013-06-07       Impact factor: 3.775

Review 4.  [Clinical aspects and care of radiogenic treatment side effects on the eye].

Authors:  Andrea M Klassen; Michael Zimbelmann; Sabine Lüken; Florian Cremers; Dirk Rades; Argyrios Chronopoulos; Felix Rommel; Mahdy Ranjbar; Salvatore Grisanti; Vinodh Kakkassery
Journal:  Ophthalmologie       Date:  2022-09-29

5.  Radiation Retinopathy 47 Years following Brachytherapy for Retinoblastoma.

Authors:  Claudine Bellerive; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2017-11-03

Review 6.  Effects of radiotherapy on uveal melanomas and adjacent tissues.

Authors:  C Groenewald; L Konstantinidis; B Damato
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

7.  Vitrectomy with internal limiting membrane removal for clinically significant macular oedema.

Authors:  Ferenc Kuhn; Gyöngyi Kiss; Viktória Mester; Zsuzsanna Szijártó; Bálint Kovács
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-18       Impact factor: 3.117

8.  Radiation Macular Edema after Ru-106 Plaque Brachytherapy for Choroidal Melanoma Resolved by an Intravitreal Dexamethasone 0.7-mg Implant.

Authors:  Andrea Russo; Teresio Avitabile; Maurizio Uva; Salvatore Faro; Livio Franco; Marisa Sanfilippo; Seby Gulisano; Mario Toro; Vittorio De Grande; Stefania Rametta; Laura Foti; Antonio Longo; Michele Reibaldi
Journal:  Case Rep Ophthalmol       Date:  2012-02-25

9.  High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular Edema.

Authors:  Mohammed Ali Khan; Arman Mashayekhi; Kyle Ferguson; Jerry A Shields; Carol L Shields
Journal:  Ocul Oncol Pathol       Date:  2017-01-27

Review 10.  Radiation retinopathy: case report and review.

Authors:  Abha Gupta; Felipe Dhawahir-Scala; Amy Smith; Lorna Young; Steve Charles
Journal:  BMC Ophthalmol       Date:  2007-04-05       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.